Antiplatelet agents for the treatment of adults with COVID-19-Reference-Cited by-同舟云学术

Antiplatelet agents for the treatment of adults with COVID-19

Published:2023-07-25 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Fischer Anna-Lena¹,Messer Sarah²,Riera Rachel³⁴⁵,Martimbianco Ana Luiza C³⁴⁶,Stegemann Miriam⁷,Estcourt Lise J⁸,Weibel Stephanie⁹,Monsef Ina²,Andreas Marike²,Pacheco Rafael L⁴⁵¹⁰,Skoetz Nicole²

Affiliation:

1. Department of Anaesthesia and Intensive care; Universitätsklinikum Leipzig; 04103 Leipzig Germany

2. Cochrane Haematology, Department I of Internal Medicine; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

3. Cochrane Brazil Rio de Janeiro; Cochrane; Petrópolis Brazil

4. Center of Health Technology Assessment; Hospital Sírio-Libanês; São Paulo Brazil

5. Núcleo de Ensino e Pesquisa em Saúde Baseada em Evidências, Avaliação Tecnológica em Saúde e Eduação em Saúde (NEP-Sbeats); Universidade Federal de São Paulo (Unifesp); São Paulo Brazil

6. Universidade Metropolitana de Santos (UNIMES); Santos Brazil

7. Department of Infectious Diseases and Respiratory Medicine; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

8. Haematology/Transfusion Medicine; NHS Blood and Transplant; Oxford UK

9. Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine; University Hospital Wuerzburg; Wuerzburg Germany

10. Centro de Pesquisa Médica; Centro Universitário São Camilo (CUSC); São Paulo Brazil

Publisher

Wiley

Subject

Pharmacology (medical)

Reference103 articles.

1. Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: a randomized clinical trial;Berger;JAMA,2022

2. Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A) clinicaltrials.gov/ct2/show/NCT04505774

3. Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: (COVID-PACT);Bohula;Circulation,2022

4. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: The ACTIV-4B randomized clinical trial;Connors;JAMA,2021

5. COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 clinicaltrials.gov/ct2/show/NCT04498273

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study;Medicina;2024-05-15

2. Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study;Scientific Reports;2024-02-28

3. What are the effects of antiplatelet agents for the treatment of adults with COVID-19?;Cochrane Clinical Answers;2023-09-05